Clover Health to Report Second Quarter 2024 Financial Results on August 5
22 Julio 2024 - 3:05PM
Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”),
a physician enablement technology company committed to bringing
access to great healthcare to everyone on Medicare, today announced
that it will report second quarter 2024 financial results after
market close on Monday, August 5, 2024. Management will host a
conference call and webcast at 5:00 p.m. Eastern Time on August 5,
2024, to discuss Clover Health’s business and financial results.
Second Quarter 2024 Conference Call and Webcast Details:
- What: Clover Health’s Second Quarter 2024 Earnings Conference
Call
- When: Monday, August 5, 2024, at 5:00 p.m. Eastern Time
- Dial In: To access the call via telephone please dial
800-245-3047 (for U.S. callers) or 203-518-9765 (for callers
outside the U.S.) and enter the conference ID: CLOVQ224
- Webcast: A live and archived webcast of the conference call
will be accessible from the Investor Relations section of Clover
Health’s website at https://investors.cloverhealth.com/ for 12
months
About Clover Health:Clover Health (Nasdaq:
CLOV) is a physician enablement technology company committed to
bringing access to great healthcare to everyone on Medicare. This
includes a health equity-based focus on seniors who have
historically lacked access to affordable, high-quality healthcare.
Our strategy is powered by our software platform, Clover Assistant,
which is designed to aggregate patient data from across the
healthcare ecosystem to support clinical decision-making and
improve health outcomes through the early identification and
management of chronic disease. For our members, we provide PPO and
HMO Medicare Advantage plans in several states, with a
differentiated focus on our flagship wide-network, high-choice PPO
plans. For healthcare providers outside Clover Health's Medicare
Advantage plan, we aim to extend the benefits of our data-driven
technology platform to a wider audience via our subsidiary,
Counterpart Health, and to enable enhanced patient outcomes and
reduced healthcare costs on a nationwide scale. Clover Health has
published data demonstrating the technology’s impact on Medication
Adherence, as well as the earlier identification and management of
Diabetes and Chronic Kidney Disease.
Press Contact:Andrew
Still-Baxterpress@cloverhealth.com
Investor Relations Contact:Ryan
Schmidtinvestors@cloverhealth.com
Clover Health Investments (NASDAQ:CLOV)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Clover Health Investments (NASDAQ:CLOV)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024